GRAPPA and ePharmaSolutions Partner to Improve Clinical Education for Psoriasis and Psoriatic Arthritis
Cloud-based training collaboration delivers clinically relevant information anywhere.
CONSHOHOCKEN, Pa., March 18, 2014 /PRNewswire/ — The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) and ePharmaSolutions, a leading clinical services and eClinical solutions provider, today announced their partnership to build and deliver online learning courses to clinicians working in psoriasis (PsO) and psoriatic arthritis (PsA) research and development.
Via the ePharmaSolutions eClinical platform, GRAPPA is able to offer training designed to standardize the use of rating scales for PsO and PsA, improving endpoint reliability in research trials in a cost-effective manner.
“We are very excited to be collaborating with ePharmaSolutions,” says Pam Love, Executive Director at GRAPPA. “Our members are enthusiastic about sharing their expertise in psoriasis and psoriatic arthritis with the research industry, and the ePharmaSolutions platform enables us to deliver this knowledge efficiently to clinicians around the world.”
According to Dr. Kristina Callis Duffin, M.D., Assistant Professor of Dermatology at the University of Utah, GRAPPA Board member and leader of this initiative, “With growing interest from regulators about training of psoriasis assessments, standardizing the approach to their use and training clinicians about them is vital to clinical research success.”
“ePharmaSolutions is proud to be a partner with GRAPPA and look forward to developing solutions that help improve endpoint reliability studies with subjective endpoints,” states Lance Converse, Founder & CEO of ePharmaSolutions. “Offering cloud-based online solutions that can be accessed easily and globally will extend our expertise deeply into dermatology and rheumatology for endpoint reliability certifications” added Converse.
ePharmaSolutions is a leading provider of eClinical solutions that help improve the way trial sites are selected, trained, activated and managed to exceed enrollment goals. ePharmaSolutions has won multiple Bio-IT World Awards for best clinical trial technology and has activated and trained more than 300,000 clinical researchers in 135 countries for the top 20 pharmaceutical companies and CROs in the world. ePharmaSolutions is headquartered in Philadelphia with offices in Slough, UK. For more information, visit www.epharmasolutions.com or email email@example.com.
GRAPPA (Group for Research and Assessment of Psoriasis and Psoriatic Arthritis) is organized exclusively for non-profit, educational, and scientific purposes, specifically to facilitate sharing of information related to psoriasis and psoriatic arthritis, networking among different medical disciplines that see psoriasis and psoriatic arthritis patients and to enhance research, diagnosis, and treatment of psoriasis and psoriatic arthritis.
GRAPPA comprises a membership of more than 450 thought leaders and includes rheumatologists, dermatologists, radiologists, geneticists, methodologists, epidemiologists, representatives from patient service leagues, and biopharmaceutical industry representatives.